Ophthalmology, Neuro-ophthalmology · Flushing, NY
NPI
1124256581
Since 2009
Specialty
Ophthalmology, Neuro-ophthalmology
Code 207WX0109X
Group practices
2
Medicare group memberships
Hospitals
0
Hospital affiliations
15814 Northern Blvd, Ml6
Flushing, NY, 11358
Phone (919) 428-1621
Groups this clinician bills Medicare through
Medicare paid, 2024
$33K
318 services
Medicare patients, 2024
88
Average age 75
Drug cost, 2024
$2.8M
7,375 prescriptions
Company payments, 2025
$483
From 8 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Bokkwan Jun was code 99215 (office e&m - established), 83 times for 54 patients. In total Bokkwan Jun billed 318 services in 18 codes, and Medicare paid $33K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2023-06-20.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99215 Office E&M - Established | Office | 83 | 54 | $145.51 | $12K |
| 92134 Computerized Ophthalmic Imaging | Office | 66 | 54 | $32.91 | $2,172 |
| 92133 Computerized Ophthalmic Imaging | Office | 50 | 41 | $27.14 | $1,357 |
| 99205 Office E&M - New | Office | 41 | 41 | $178.52 | $7,319 |
| 68810 Eye | Office | 13 | 11 | $195.34 | $2,539 |
By year: 2022 $220K for 2,985 services; 2023 $109K for 1,310 services; 2024 $33K for 318 services.
Medicare prescription drug claims, 2024
In 2024, the drug Bokkwan Jun prescribed most often to Medicare patients was Restasis (Cyclosporine), with 2,502 prescriptions and refills. In total Bokkwan Jun wrote 7,375 Medicare prescriptions that cost $2.8M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Restasis Cyclosporine | 2,502 | 2,780 | 500 | $1.8M |
| Neomycin-Polymyxin-Dexameth Neomycin/Polymyxin B/Dexametha | 813 | 847 | 378 | $11K |
| Latanoprost Generic | 759 | 1,301 | 171 | $6,166 |
| Tobramycin-Dexamethasone Tobramycin/Dexamethasone | 609 | 755 | 321 | $31K |
| Azelastine Hcl Generic | 555 | 585 | 214 | $10K |
| Ofloxacin Generic | 356 | 407 | 169 | $5,341 |
| Prednisolone Acetate Generic | 309 | 448 | 156 | $15K |
| Xiidra Lifitegrast | 253 | 283 | 62 | $197K |
| Ketorolac Tromethamine Generic | 182 | 225 | 101 | $6,879 |
| Lumigan Bimatoprost | 160 | 280 | 36 | $81K |
| Timolol Maleate Generic | 106 | 141 | 27 | $523 |
| Dorzolamide-Timolol Dorzolamide Hcl/Timolol Maleat | 85 | 124 | 23 | $673 |
| Alphagan P Brimonidine Tartrate | 77 | 102 | 12 | $29K |
| Cyclosporine Generic | 66 | 78 | 44 | $19K |
| Bepotastine Besilate Generic | 49 | 73 | 14 | $7,971 |
Brand drugs: 4,050 claims; generic drugs: 3,325 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Bokkwan Jun $483 ($483 in general payments such as food, travel and fees) from 8 companies. The largest payer was Amgen Inc. with $144.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.